[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0112123A - Composto - Google Patents

Composto

Info

Publication number
BR0112123A
BR0112123A BR0112123-5A BR0112123A BR0112123A BR 0112123 A BR0112123 A BR 0112123A BR 0112123 A BR0112123 A BR 0112123A BR 0112123 A BR0112123 A BR 0112123A
Authority
BR
Brazil
Prior art keywords
dpp
obesity
inactivation
diabetes
proteins
Prior art date
Application number
BR0112123-5A
Other languages
English (en)
Inventor
Anders Bendtz Kanstrup
Lise Brown Christiansen
Jane Marie Lundbeck
Christian K Sams
Marit Kristiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/DK2001/000467 external-priority patent/WO2002002560A2/en
Publication of BR0112123A publication Critical patent/BR0112123A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSTO". A presente invenção refere-se a inibidores terapeuticamente ativos e seletivos da enzima DPP-IV, a composições farmacêuticas compreendendo os compostos e ao uso de tais compostos e à manufatura de medicamentos para tratar doenças que são associadas com as proteínas que são sujeitas a inativação pela DPP-IV, tais como diabetes tipo 2 e obesidade.
BR0112123-5A 2000-07-04 2001-07-04 Composto BR0112123A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001040 2000-07-04
PCT/DK2001/000467 WO2002002560A2 (en) 2000-07-04 2001-07-04 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)

Publications (1)

Publication Number Publication Date
BR0112123A true BR0112123A (pt) 2003-05-06

Family

ID=8159598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112123-5A BR0112123A (pt) 2000-07-04 2001-07-04 Composto

Country Status (13)

Country Link
EP (1) EP1561752A1 (pt)
KR (1) KR20030014394A (pt)
CN (1) CN1440288A (pt)
AT (1) ATE299024T1 (pt)
BR (1) BR0112123A (pt)
CA (1) CA2411864A1 (pt)
CZ (1) CZ200319A3 (pt)
DE (1) DE60111849T2 (pt)
ES (1) ES2244634T3 (pt)
IL (1) IL153182A0 (pt)
NO (1) NO20030021L (pt)
RU (1) RU2003103103A (pt)
ZA (1) ZA200209714B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127053A (zh) * 2004-03-15 2011-07-20 武田药品工业株式会社 二肽基肽酶抑制剂
EP1794120B1 (en) * 2004-07-23 2012-04-11 Nuada, LLC Peptidase inhibitors
CN102276627B (zh) * 2010-04-29 2013-07-31 山东轩竹医药科技有限公司 吡啶并杂环衍生物
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
CN103509023B (zh) * 2012-06-20 2014-08-27 成都苑东药业有限公司 黄嘌呤衍生物
NZ711718A (en) * 2013-03-15 2020-05-29 Hydra Biosciences Llc Substituted xanthines and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205815A1 (de) * 1972-02-08 1973-08-16 Hoechst Ag Piperazinderivate und verfahren zu ihrer herstellung
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
IL153182A0 (en) 2003-06-24
EP1561752A1 (en) 2005-08-10
CA2411864A1 (en) 2002-01-10
NO20030021D0 (no) 2003-01-03
DE60111849D1 (de) 2005-08-11
KR20030014394A (ko) 2003-02-17
NO20030021L (no) 2003-03-03
ATE299024T1 (de) 2005-07-15
DE60111849T2 (de) 2006-06-08
RU2003103103A (ru) 2004-08-20
CN1440288A (zh) 2003-09-03
CZ200319A3 (cs) 2003-05-14
ES2244634T3 (es) 2005-12-16
ZA200209714B (en) 2003-08-19

Similar Documents

Publication Publication Date Title
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
WO2004033455A3 (en) Hemisuccinate salts of heterocyclic dpp-iv inhibitors
WO2003024965A3 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
NO2007010I2 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE60330485D1 (de) Zur behandlung von diabetes
BR0009167A (pt) Inibidores de enzima impdh
CY1108146T1 (el) ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ
ATE244717T1 (de) Inhibitoren des impdh-enzyms
MY138708A (en) Biaryloxymethylarenecarboxylic acids
ATE408601T1 (de) Fredericamycin-derivate
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
DE602004030222D1 (de) 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
GB0222495D0 (en) Compounds
WO2005065195A3 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
ATE384058T1 (de) Thiazolderivate
DE60315479D1 (de) Pyrimidinamid derivate und deren verwendung
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
AU2003260436A1 (en) Pyrimidine compounds
BR0112123A (pt) Composto
SE0000303D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.